Latest Health News

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

ImpediMed has secured FDA 510(k) clearance for its SOZO Digital Health Platform to assess sarcopenia risk, marking it as the only FDA-cleared bioimpedance spectroscopy solution for this clinical application. This clearance enables clinicians to non-invasively monitor muscle loss in cancer and chronic disease patients, potentially improving treatment outcomes.

Healius Limited posted a modest revenue increase and underlying loss improvement for FY26, overshadowed by a substantial non-cash goodwill impairment and ongoing sector pressures.

Service Stream Limited (ASX: SSM) posted a modest 1.1% revenue rise to $2.35 billion for FY26, driven by Utilities and Asset & Facility Management growth, including a new Defence contract. EBITDA from operations surged 11.8% to $163.4 million, while statutory NPAT dipped 3.8% due to $21.2 million in ERP modernization costs. The company declared a final dividend increase to 3.5 cents per share.

Viva Leisure posted a 12.2% revenue increase to $237.1 million and a 144.5% jump in net profit after tax for FY2026, declaring its first fully franked dividend and launching Meridium Global as a standalone payments and technology business.

AVITA Medical's PermeaDerm biosynthetic wound matrix delivers clinical outcomes on par with allograft while slashing treatment costs by 70%, according to a new multicenter study.

EBOS Group posted a solid FY26, growing revenue nearly 10% to $13.5 billion and underlying EBITDA 5% to $614 million, while completing a major distribution centre renewal program. The company maintains its final dividend and sets a confident growth outlook for FY27.

Pro Medicus delivered a robust FY26 with 28% underlying revenue growth, a surge in new contract wins worth $407 million, and a 25% increase in fully franked dividends, underpinned by strong AI product development and rapid implementations.

Macmahon Holdings delivered a tenth consecutive year of growth with revenue up 7.9% to $2.6 billion and net profit after tax soaring 36.8% to $101.1 million, underpinned by strong contract wins and operational discipline.

Synertec Corporation Limited (ASX:SOP) reported a 19% revenue increase in FY26 alongside its first net operating cash inflow since FY19. The company raised approximately A$6 million through an institutional placement to support working capital and growth initiatives while reaffirming FY27 revenue guidance.

Doctor Care Anywhere delivered a 27% rise in EBITDA and doubled free cash flow in H1 2026, driven by operational efficiencies and a strategic entry into the UK weight management market via acquisition.

GWA Group posted modest revenue and earnings growth in FY26, driven by volume gains across Australia, New Zealand, and the UK, while raising dividends and advancing strategic priorities despite challenging market conditions.